In highly purified human polymorphonuclear leukocyte (PMN) preparations containing less than 0.1% contaminating monocytes, significant amounts of interleukin-8 (IL-8) and small amounts of IL-la, IL-la, and tumor necrosis factoralpha (TNF-a) were produced by lipopolysaccharide (LPS) stimulation. Contrary to published reports, IL-6 production could not be detected. IL-10 inhibited the production of ILla, IL-IP, IL-8, and TNF-(r in LPS-stimulated PMNs, as it did in human blood mononuclear cell (MNC) preparations enriched in monocytes. Subsequent investigation of cytokine synthesis inhibitory effect of IL-10 on PMNs was focused on IL-8. IL-10 inhibited IL-8 synthesis in a dose-dependent NTERLEUKIN-10 (IL-10) is a newly identified cytokine with a molecular weight of 18 k D , which was initially described as cytokine synthesis inhibitory factor.'.' IL-10 inhibits production of a wide range of cytokines in various cell types, such as IL-1, IL-6, IL-8, and tumor necrosis factor-alpha (TNF-a) in macrophages/monocytes3~5; IL-2, IL-3, lymphotoxin, interferon-y, and granulocyte-macrophage colony-stimulating factor (GM-CSF) in Thl IL-4 and IL-5 in Th2 cells'; and interferon-y and TNF-a in natural killer cell^.^^'^ Because many of these cytokines (IL-l, IL-6, IL-8, and TNF-a) are important inflammatory mediators, IL-10 may offer clinical utility as an antiinflammatory agent.'" It has been reported that human polymorphonuclear leukocytes (PMNs) produce various cytokines, including IL-6,",'' IL-l,'1,'3"5 TNF-CX,".'~"~ and IL-8."~'9~2' On a cell basis, the production of these cytokines from PMNs is much less than that from monocytes, which are the principal producers of all these cytokines. Nevertheless, there may be a significant contribution of PMNs to the overall cytokine production during inflammation, because of the quantitative predominance of PMNs over monocytes in the peripheral blood and at sites of acute inflammation.
NTERLEUKIN-10 (IL-10) is a newly identified cytokine
with a molecular weight of 18 k D , which was initially described as cytokine synthesis inhibitory factor.'.' IL-10 inhibits production of a wide range of cytokines in various cell types, such as IL-1, IL-6, IL-8, and tumor necrosis factor-alpha (TNF-a) in macrophages/monocytes3~5; IL-2, IL-3, lymphotoxin, interferon-y, and granulocyte-macrophage colony-stimulating factor (GM-CSF) in Thl IL-4 and IL-5 in Th2 cells'; and interferon-y and TNF-a in natural killer cell^.^^'^ Because many of these cytokines (IL-l, IL-6, IL-8, and TNF-a) are important inflammatory mediators, IL-10 may offer clinical utility as an antiinflammatory agent. '" It has been reported that human polymorphonuclear leukocytes (PMNs) produce various cytokines, including IL-6,",'' IL-l,'1,'3"5 TNF-CX,".'~"~ and IL-8."~'9~2' On a cell basis, the production of these cytokines from PMNs is much less than that from monocytes, which are the principal producers of all these cytokines. Nevertheless, there may be a significant contribution of PMNs to the overall cytokine production during inflammation, because of the quantitative predominance of PMNs over monocytes in the peripheral blood and at sites of acute inflammation.
In the present report, we show that human PMNs respond to lipopolysaccharide (LPS) by generating significant amounts of IL-8 and small amounts of IL-1 and TNF-a, and that IL-10 inhibits this cytokine production by affecting both mRNA synthesis and degradation.
I MATERIALS AND METHODS

Preparation of MNCs and PMNs.
Fifty milliliters of venous blood from a healthy male donor was mixed with 5 mL of a buffer consisting of 3.8% sodium citrate and 2% dextrose. Mononuclear cells (MNCs) and PMNs were prepared as described:' with some modifications. Briefly, after dextran sedimentation of red blood cells, the plasma was layered carefully onto Ficoll-Paque (Pharmacia, Pis-manner and, in this regard, it was more potent than IL-4 and transforming growth factor-j?l (TGF-91). In both MNCs and PMNs, degradation of LPS-induced IL-8 mRNA was enhanced by IL-10. Furthermore, as determined by nuclear runon assays, IL-10 inhibited LPS-induced transcription of IL-8 gene in MNCs. However, in PMNs, run-on assays could not reliably detect IL-8 gene transcription. These resutts provide the first evidence that the human peripheral neutrophil is a target for inhibition of cytokine synthesis by IL-10, and that IL-10 acts by affecting both gene transcription and mRNA stability.
0 1994 by The American Society of Hematology.
cataway, NJ). After centrifugation, MNCs at the interface were carefully transferred to a clean tube with a Pasteur pipette, and washed with phosphate-buffered saline (PBS) and then with cell culture medium (see below). The concentrations of monocytes in MNC preparations were 15% to 30% depending on the donors, as determined by nonspecific esterase cytochemical method using an anaphthyl acetate esterase staining kit (Sigma, St Louis, MO).
To further purify PMNs, the remainder of the Ficoll-Paque phase was completely removed with a fresh Pasteur pipette. The tube wall was carefully washed with PBS, and the cell pellet on the bottom of the tube was suspended in 5 mL of PBS. The suspension was transferred to a new tube and erythrocytes were lysed by adding 40 mL of ice-cold water. PMNs were recovered by centrifugation, washed, and resuspended in the cell culture medium (see below). The content of monocytes in these PMN preparations was 0.1% or less, as determined by the nonspecific esterase cytochemical method.
Cell culture. Cells were cultured in RPM1 1640 medium supplemented with 1% each of penicillin and streptomycin, nonessential amino acids, sodium pyruvate, glutamine (all from GIBCO, Grand Island, NY) and 5% heat-inactivated fetal calf serum (FCS; Hyclone, Logan, UT) in a humidified atmosphere of 5% COz at a cell density of 1 X 106/mL, in the presence of appropriate agents as specified. The incubation was performed for 14 and 12 hours for cytokine protein assays and Northern blot analysis, respectively.
Assays for cytokine protein production. Cytokine protein amounts in cell culture supernatants were determined by using commercially available enzyme-linked immunosorbent assay (ELISA) kits (IL-6 and TNF-a kits from Biosource, Camarillo, CA; IL-la, IL-10, and IL-8 kits from R & D Systems, Minneapolis, MN).
Northern blot analysis. Total cellular RNA was isolated using RNAzol solution (Biotex Laboratories, Houston, TX) according to the manufacturer's instructions. RNA electrophoresis was performed on a 1 % agarose-formaldehyde gel, and fractionated RNA was then transfened to Duralon UV Membranes (Stratagene, La Jolla, CA) with a PosiBlot pressure blotter (Stratagene). Prehybridization was performed at 42°C for 2 hours in a solution of 5X SSC, 5X Denhardt's reagent, 50 mmol/L sodium phosphate, 0.1 % sodium dodecyl sulfate (SDS), 5 mmol/L EDTA, 50% formamide, 50 pglmL denatured salmon sperm DNA, and 50 Fg/mL denatured torula yeast RNA. IL-8 and L -6 mRNAs were detected by hybridization with respective cDNA probes (R & D Systems) labeled with "P by the random primer labeling method. The hybridization was performed at 42°C for 18 hours in a solution of 5X SSC, 1 X Denhardt's reagent, 20 mmoVL sodium phosphate, 0.1% SDS, 5 mrnoVL EDTA, 50% formamide, 50 pg/mL denatured salmon sperm DNA, and 50 pgl mL denatured torula yeast RNA. After the hybridization, membranes were washed with 2 x SSC/O.l% SDS twice at room temperature, each for 10 minutes, then once at 50°C for 30 minutes, and finally with 0.1 x SSC/O.I % SDS at room temperature for 5 minutes.
0-Actin cDNA probe (Clontech, Palo Alto, CA) was labeled with biotin, and detected by the streptavidin-alkaline phosphatase method. or PMNs (1 X 10' cells per sample) were cultured in the absence or the presence of various agents. After selected times, cells were collected, nuclei prepared, and nuclear run-on assays with some minor modifications. Briefly, nuclei from each sample were suspended in 0.2 mL of TEG buffer (50 mmom Tris-HC1, pH 8.3,5 mmol/L MgC12, 0.1 mmolfL EDTA, 40% glycerol). Elongation of nascent RNA chains was initiated by mixing this nuclear suspension with 0.2 mL of reaction buffer, which contained 10 mmoVL Tris-HC1, pH 8.0, 5 mmoVL MgC12, 0.3 moVL KCI, 12.5 mmoVL dithiothreitol, 2.5 mmoVL each of adenosine triphosphate (ATP), cytidine triphosphate (CTP), and guanosine triphosphate (GTP), 80 U RNasin (Promega, Madison, W), and 0.1 mCi [32P]uridine triphosphate (UTP) (specific activity, 3,000 Cilmmol; New England Nuclear, Boston, MA). After incubation at 37°C for 1 hour, "Plabeled RNA was isolated and dissolved in 0.4 mL of TES buffer mom NaC1, and 5% dextran sulfate), then analyzed as follows.
Cytokine cDNA inserts and p-actin cDNA probe, 250 ng each, were immobilized on Nytran membrane (Schleicher & Schuell, Keene, NH) and the membrane was prehybridized overnight at 60°C in a solution of 5 x SSC, 5X Denhardt's reagent, 50 mmoVL sodium phosphate, 1X Blocking Solution (Biotex), 5% SDS, 5 mmoVL EDTA, and 5% dextran sulfate. Labeled RNA was hybridized with immobilized cDNA probes at 65°C for 3 days and the membrane was washed three times, each for 30 minutes, with 2X SSC at 6 0 T , then twice, each for 20 minutes, with 2X SSC containing 10 pg/mL RNase A (Sigma) at 37"C, and finally once for 1 hour with 2X SSC at 37°C.
Other reagents. Recombinant human &l0 and IL-4 were from Schering-Plough Research Institute (Union, NJ). Natural human transforming growth factor-p1 (TGF-81) was obtained from Genzyme (Cambridge, MA). LPS was purchased from Sigma.
Data presentation. Assays for cytokines were performed in duplicate. Each set of experiments were performed at least twice and the data presented are from representative experiments. Data points are the mean of two determinations, which were within lo%, mostly 5%. of the mean. 
LPS-stimulated PMNs produce IL-I, IL-8, and TNF-a, but
not IL-6. It has been reported that PMNs produce IL-1, IL-6, IL-8, and TNF-a."-*' To investigate the effect of IL-10 on cytokine production by PMNs, it is critical to use PMN preparations free of contaminating monocytes, because monocytes are the principal producers of all these cytokines, and also because monocytes are the primary target for IL-10 a~ti0n.l.~ Table 1 shows the effect of monocyte contamination on LPS-induced cytokine production by PMN preparations. In a highly purified PMN preparation containing only approximately 0.1 % contaminating monocytes, significant amounts of IL-8 and small amounts of IL-la, IL-lB, and TNF-a were produced, but IL-6 was undetectable. In contrast, PMN preparations obtained using standard procedures," which deferred from ours in that we exercised extreme caution in removing the Ficoll-Paque phase and washed the tube wall to minimize monocyte contamination, contained approximately 0.8% monocytes and produced IL-6 in significant amounts. Because IL-6 is a marker for monocyte contamination, it would appear that the IL-la, IL-lp, TNF-a, and IL-8 were derived from PMNs, rather than from contaminating monocytes in our highly purified PMN preparation. PMNs were prepared using standard procedures (Standard PMNs) or by modified procedures (Pure PMNs) described in the present report. These three cell preparations were obtained from the same donors at the same time. Cells were suspended in culture medium at a density of l x 106/mL, and IL-10 (10 ng/mL) was added 5 minutes before LPS (80 ng/mL). Appropriate controls containing no IL-10 or LPS were also included. Cell suspensions were then incubated for 14 hours before collecting supernatants for cytokine quantification by ELISAs. Other details are provided in Materials and Methods.
* Monocyte content (%).
When MNCs were added in known increments to the highly purified PMN preparation then stimulated with LPS, there were proportional increases in both IL-6 (Fig IA) and IL-8 ( Fig 1B) . Extrapolation of IL-6 and IL-8 curves to the MNC-free condition indicated release of IL-8, but not IL-6, supporting the contention that, under our experimental conditions, LPS-stimulated human neutrophils do not produce L-6.
MNCs responded to low concentrations of LPS by producing significant amounts of IL-8 (ED5o < 0.02 ng/mL) (Fig   2A) , while IL-8 production in PMNs required relatively higher LPS concentrations (ED5o 4 6 ng/mL) (Fig 2B) . IL-8 production in MNCs plateaued at 0.64 ng/mL of LPS, a concentration at which there was no IL-8 or IL-6 production in PMNs, indicating, again, that there was no significant monocyte contamination in our PMN preparation. This difference in sensitivity of MNCs and PMNs to LPS may well be due to the fact that monocytes produce IL-1 and TNF-a in large quantities and that these cytokines act synergistically with LPS to stimulate IL-8 production from monocytes.24 IL-6 was produced in large amounts by MNCs at all LPS concentrations, while PMNs produced IL-6 at barely detectable levels, even at the highest LPS concentration (400 ng/ mL). These results further indicate that our PMN preparations were essentially devoid of contaminating monocytes, and that, under our experimental conditions, PMNs generate IL-8, but not IL-6. IL-IO inhibits LPS-induced cytokine production in human PMNs. The effects of IL-10 on IL-8 and IL-6 synthesis were studied in both PMNs and MNCs (Fig 3) . In all cases, IL-10 inhibited cytokine synthesis in a dose-dependent manner, although PMNs were less sensitive to IL-l0 than were MNCs. In the same set of experiments, we also investigated the effects of IL-4 and TGF-P1 on cytokine production, because IL-4 and TGF-P1 inhibited cytokine synthesis in monocytes/macrophages.z5~z7 Since optimal concentrations of IL-4 and TGF-P1 for cytokine synthesis inhibition were reported to be 1 to 10 ng/mL,25327 in our experiments, we used IL-4 and TGF-01 at concentrations ranging from 0.1 to 100 ng/mL. Both IL-4 and TGF-01 caused modest inhibition of IL-8 production in MNCs, while IL-4, but not TGFpl, inhibited IL-8 production in PMNs. IL-6 production in MNCs was inhibited effectively by IL-4, but TGF-01 was marginally inhibitory. In both cell preparations, E-10 was the most potent inhibitor of cytokine synthesis.
IL-l0 acts by affecting IL-8 mRNA metabolism. IL-l0 inhibited cytokine production by acting at the level of mRNA (Fig 4) . LPS caused a dramatic increase of IL-8 mRNA in both PMNs and MNCs. The IL-8 mRNA, whose apparent molecular size has been reported to be 1.8 kb, was detected on our Northern blots as broad bands, suggesting its conversion into smaller components due possibly to long exposure to LPS. Nevertheless, this IL-8 accumulation was effectively inhibited by 20 ng/mL of IL-10. In MNCs, IL-6 mRNA was produced at a level comparable to that of IL-8 &A, while IL-6 mRNA was undetectable in PMNs. This is consistent with the observation that LPS-stimulated PMNs are incapable of IL-6 synthesis (Table 1 and Figs 1 and 2) . The IL-6 mRNA accumulation in MNCs was also inhibited by IL-10.
To determine whether IL-10 suppresses IL-8 mRNA accumulation by inhibiting transcription of the gene, nuclear run-on assays were performed. Four separate run-on experiments using nuclear preparations from LPS-stimulated PMNs showed little or no IL-8 mRNA synthesis (data not shown), possibly due to low transcriptional rates in PMNs. However, in MNCs, LPS enhanced transcription of IL-8 gene, and this enhanced transcription was inhibited by IL-10 ( Fig 5) . To examine whether IL-10 also acts at the level of mRNA stability, cells were stimulated with LPS in the absence or the presence of IL-10, and then mRNA synthesis was stopped by adding actinomycin D. Over the subsequent 2-to 3-hour period, IL-8 mRNA was evaluated by Northern analysis. As shown in Fig 6, in both PMNs and MNCs, degradation of IL-8 mRNA was significantly enhanced by IL-10. These results indicate that IL-10 suppresses IL-8 synthesis by acting at the level of both gene transcription and mRNA degradation.
DISCUSSION
Using highly purified neutrophil preparations containing less than 0.1% monocytes, we conclude in the present study that human peripheral neutrophils respond to LPS by generating several inflammatory cytokines, including IL-1, IL-8, and TNF-a. IL-8 is produced in large quantities, while the production of IL-1 and TNF-a is rather limited (Table l) . see Table 1 . MNCs. There was no detectable IL-6 production in PMNs.
A previous study has used an immunocytochemical approach to demonstrate that LPS-stimulated PMNs do generate both IL-la and IL-I/?.I4 Several previous studies have also claimed IL-6 production by LPS-and GM-CSF-stimulated However, in the present study, we have found no indication of IL-6 production as evaluated by protein ELISA at a detection level of 5 pg/mL or by Northern blotting upon stimulation with LPS ( Table 1 and Fig 4) or with GM-CSF (data not shown). Recent in situ hybridization experiments have concluded that neutrophils do produce IL-6, but only when they are in circulation, and that they lose this ability following their withdrawal from the blood stream. 28 These observations indicate that PMN preparations used in the previous studies may have contained monocytes in sufficient numbers to account for the IL-6 production. Incubations were conducted for 12 hours, then the total RNA extracted; 10 p g of each sample from both PMNs and MNCs was subjected to Northern blot analysis. Each filter membrane was probed sequentially with 11-6, IL-8, and p-actin cDNAs. A 0.24-t o 9.5-kb RNA ladder (Life Technologies, Gaithersburg, MD) was used as a size marker. Details are described in Materials and Methods.
IL-8
p-actin Indeed, IL-6 is readily detected in neutrophil preparations containing 0.6% to 0.8% monocytes (Table 1) .
That IL-10 inhibits cytokine synthesis in monocytes and T cells is well established."'0 Our present results show for the first time that IL-10 also acts on PMNs to inhibit LPSinduced cytokine synthesis. This effect of IL-10 on E -8 production is dose-dependent (Fig 3) and involves a reduction in the cytokine mRNA level (Fig 4) . In these regards, PMNs bear striking similarities with monocytes (Figs 3 and  4) . The exquisite sensitivity of neutrophils to E -l 0 (1 ng/ mL = 56 pmol/L) clearly indicates that IL-l0 exerts its inhibitory action on PMNs by interacting with specific receptors.
Mechanisms by which IL-10 reduces cytokine mRNA accumulation in stimulated cells are largely unknown. A recent study in murine peritoneal macrophages has indicated that IL-10 may act by enhancing the degradation of cytokine mRNA." In support of this observation, we find that L -l 0 enhances IL-8 mRNA degradation in both MNCs and PMNs (Fig 6) . We further find that IL-10 is capable of inhibiting IL-8 gene transcription (Fig 5) . Thus, the inhibitory action of IL-10 on IL-8 mRNA appears to be the consequence of both inhibition of gene transcription and enhancement of mRNA degradation.
Compared with monocytes, PMNs are poor producers of inflammatory cytokines, including IL-1, IL-8, and TNF-a. Nevertheless, the overall contribution of PMNs to the in vivo production of inflammatory cytokines may be significant, because of quantitative predominance of PMNs over monocytes in the peripheral blood and at the sites of acute inflammation. Thus, the current finding that IL-10 inhibits cytokine production by PMNs underscores the potential importance of E-10 in the regulation of PMN-mediated inflammatory processes.
